"The U.S. Food and Drug Administration today approved Cometriq (cabozantinib) to treat medullary thyroid cancer that has spread to other parts of the body (metastasized).
Medullary thyroid cancer develops in cells in the thyroid gland that m"...
Patients should be advised that if they become pregnant during therapy or intend to become pregnant, they should contact their physician immediately about the desirability of discontinuing the drug. They also should not use propylthiouracil (propylthiouracil (propylthiouracil (propylthiouracil tablet) tablet) tablet) while nursing. Patients should report immediately any evidence of illness, particularly sore throat, skin eruptions, fever, headache, or general malaise.
They should report symptoms suggestive of hepatic dysfunction (anorexia, pruritis, right upper quadrant pain, etc).
Last reviewed on RxList: 1/25/2010
This monograph has been modified to include the generic and brand name in many instances.
Additional Propylthiouracil Information
Propylthiouracil - User Reviews
Propylthiouracil User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.